Muscle and Combo Therapies Likely Next Focus for SMA & DeAnn Runge's 3 Year Journey With Spinraza
Aug 31, 2020, 12:00 AM
SMA News Today’s multimedia associate, Price Wooldridge, discusses the likely next focus of muscle and combo therapies for Spinal Muscular Atrophy (SMA).
DeAnn Runge shares her thoughts on her 3 year journey with Spinraza.
Are you interested in learning more about spinal muscular atrophy? If so, please visit https://smanewstoday.com/